Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-14

Clinical Trial Update: Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption [NA]

View source ↗

Summary

This completed clinical trial evaluated holotranscobalamin as a biomarker for vitamin B12 absorption in individuals with a vitamin B12 disorder; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Florida | Conditions: Disorder of Vitamin B12 | NA | Status: COMPLETED | Results posted: 2011-12-14